MedTrace Logo

Dyslipidemia

Disease

Disease Profile

Dyslipidemia is a metabolic disorder characterized by abnormal blood lipid levels, including LDL cholesterol, HDL cholesterol, and triglycerides. It is often asymptomatic but is a major cardiovascular risk factor because persistent lipid abnormalities promote atherosclerosis and vascular events. Management includes lifestyle interventions and lipid-lowering therapies based on risk.

Category
Metabolic disorder of lipid metabolism
Prevalence
Global adult prevalence is estimated to range from 20% to 80%, depending on definitions and criteria
ICD Codes
  • E78.5

Related News

Blood Pressure Drug Class Linked to Worse Kidney Outcomes in Diabetic Patients, Studies Show

New research presented at the ERA Congress found DCCB blood pressure medications were associated with a 33% increased risk of major adverse kidney events in Type 2 diabetes patients also receiving RAS and SGLT2 inhibitors. A separate study revealed that diabetic nephropathy patients exhibit the most severe biochemical disturbances, including markedly elevated glycemic indices and significantly impaired renal function compared to other groups.

Related Clinical Trials

NCT ID Title Status Phase
NCT07590167

A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

 NOT_YET_RECRUITING PHASE1
NCT07581028

Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers

 NOT_YET_RECRUITING PHASE1
NCT07559110

Supplementation With Salicornia Extract Rich in Polyphenols (B-Salicornia) to Improve Vascular Health in Patients With Dyslipidemia Who Are Not Candidates for Drug Treatment (Low to Moderate Risk)

 NOT_YET_RECRUITING NA
NCT07552571

Goal Commitment and Proactive Health Behavior in Chronic Disease Patients

 RECRUITING NA
NCT07545005

Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth

 NOT_YET_RECRUITING NA
NCT07524101

Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

 NOT_YET_RECRUITING NA
NCT07515573

Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals

 NOT_YET_RECRUITING NA
NCT07515560

Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study

 NOT_YET_RECRUITING
NCT07502703

Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community

 NOT_YET_RECRUITING
NCT07476248

The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

 NOT_YET_RECRUITING